Li Jiahui, Ribo Marc
Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain.
Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Neurointervention. 2022 Jul;17(2):70-77. doi: 10.5469/neuroint.2022.00255. Epub 2022 Jun 20.
Aspiration catheters are widely used in mechanical thrombectomy procedures to treat acute ischemic stroke due to large vessel occlusion. The key performance requirements for aspiration catheters are ease of navigation and effective aspiration. In this work, we review the clinical experience and in vitro studies of REACT aspiration catheters (Medtronic, Minneapolis, MN, USA). In vitro experiments showed that REACT catheters exhibit solid performance in navigation and aspiration. Previous studies reported that the recanalization capacity of the aspiration catheters can be influenced by the devices' inner diameter and tip distensibility, the catheter-to-vessel diameter ratio, the negative pressure delivered by the vacuum generator, the cyclical aspiration mode, the proximal flow arrest, and the angle of interaction between catheter and clot. REACT catheters can be navigated through the vasculature without any support from a microcatheter/microwire in favorable anatomical configurations. In challenging situations, mostly encountered when crossing the ophthalmic segment of the internal carotid artery, the use of the stentriever anchoring technique or delivery assist catheter can facilitate the navigation. Three clinical studies reporting on 299 patients who underwent mechanical thrombectomy with REACT catheters were included in this review. Successful recanalization (modified treatment in cerebral ischemia score 2b-3) was achieved in 89-96% of cases, no procedural complications related to REACT catheters were reported, and functional independence (modified Rankin Scale 0-2) at 90-days was 24-36%. In vitro experimental evaluations and clinical studies support the safety and effectiveness of the REACT catheters.
抽吸导管广泛应用于机械取栓手术,用于治疗因大血管闭塞导致的急性缺血性卒中。抽吸导管的关键性能要求是易于操控和有效抽吸。在本研究中,我们回顾了REACT抽吸导管(美敦力公司,美国明尼阿波利斯)的临床经验和体外研究。体外实验表明,REACT导管在操控和抽吸方面表现出色。先前的研究报道,抽吸导管的再通能力可能受以下因素影响:器械的内径和尖端可扩张性、导管与血管直径比、真空发生器提供的负压、周期性抽吸模式、近端血流停滞以及导管与血栓之间的相互作用角度。在有利的解剖结构下,REACT导管无需微导管/微导丝的支持即可在血管系统中操控。在具有挑战性的情况下,主要是在穿过颈内动脉眼段时遇到的情况,使用支架取栓器锚定技术或输送辅助导管可便于操控。本综述纳入了三项关于299例使用REACT导管进行机械取栓患者的临床研究。89%至96%的病例实现了成功再通(改良脑缺血治疗评分2b - 3),未报告与REACT导管相关的手术并发症,90天时的功能独立性(改良Rankin量表0 - 2)为24%至36%。体外实验评估和临床研究支持了REACT导管的安全性和有效性。